Endosee
Los Altos, US · Founded 2011
Founders & leadership
X(
Xiaolong (Bruce) OuYangExecutive
KR
Kevin RooneyExecutive
PD
Paul D. IndmanExecutive
S(
Shih-Ping (Bob) WangExecutive
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 1 round · 2014
▶$1.8MraisedJun 2014 · 10 investors · BiotechnologyRule 506(b)
▶$1.8MraisedJun 2014 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Xiaolong (Bruce) OuYangExecutive Officer, Director
- Kevin RooneyExecutive Officer
- Paul D. IndmanExecutive Officer, Director
- Shih-Ping (Bob) WangExecutive Officer, Director
- Offering amount
- $2.6M
- Amount sold
- $1.8M
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Endosee raised?
- Endosee has disclosed $1.8M raised across 1 round.
- Where is Endosee headquartered?
- Endosee is headquartered in Los Altos, US.